Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 83 (1) , 130-136
- https://doi.org/10.1016/j.fertnstert.2004.05.098
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Metformin in polycystic ovary syndrome: systematic review and meta-analysisBMJ, 2003
- Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2003
- Ultrasound examination of polycystic ovaries: is it worth counting the follicles?Human Reproduction, 2003
- Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulationHuman Reproduction, 2003
- Anti-Müllerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse OvaryEndocrinology, 2002
- Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodentsProceedings of the National Academy of Sciences, 2001
- Polycystic ovaries and associated clinical and biochemical features in young womenClinical Endocrinology, 1999
- Fortnightly Review: Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecologyBMJ, 1998
- An Immunoassay to Detect Human Mullerian Inhibiting Substance in Males and Females during Normal Development*Journal of Clinical Endocrinology & Metabolism, 1990
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.BMJ, 1986